WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR: OCTOBER ISSUE PUBLISHED

    OCTOBER 2024 Issue has been successfully launched on OCTOBER 2024.

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR October 2024 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

A COMPARATIVE STUDY OF EFFICACY OF ORAL TERBINAFINE VERSUS ORAL ITRACONAZOLE IN TREATMENT OF TINEA CORPORIS AND TINEA CRURIS INFECTION

Sana Jum*, Hamid Suleiman and Jamal Khadam

ABSTRACT

Background: Recently, it was noted that the spread of superficial fungal infections with widespread resistance to various antifungal drugs used in the traditional dose, with an increase in relapse rates, which caused a real medical problem due to the skin manifestations and clinical symptoms (itching) disturbing to the patient. Objectives: This study was designed to evaluate and compare the efficacy of oral terbinafine versus itraconazole in the treatment of Tinea Corporis and Tinea Cruris. Materials and Methods: This was a prospective, randomized comparative study. It was conducted at Tishreen University Hospital, Lattakia, during the period between 2022-2023. The study included 90 patients. After confirming the diagnosis, the patients were randomly divided into two groups. The first group: 45 patients treated with terbinafine orally at a dose of 500 mg daily for 4 weeks. The second group: 45 patients who were treated with itraconazole orally at a dose of 200 mg daily for 4 weeks. Results: There were statistically significant differences between the two research groups regarding the evaluation of recovery between the two research groups, where we find that the cases of complete recovery amounted to 86.7% in the oral itraconazole treatment group compared to 72.7% in the terbinafine group. Conclusion: Itraconazole is better than terbinafine in the treatment of Tinea Corporis and Tinea Cruris and can be considered as the first line. The safety of both drugs, even after using higher concentrations and a longer treatment period.

[Full Text Article] [Download Certificate]